±Ù¸· ÅëÁõ ÁõÈıºÀÇ ÅëÁõ À¯¹ßÁ¡ ÁÖ»ç
Trigger Point Injection for Myofascial Pain Syndrome

´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸÁö 2014³â 7±Ç 2È£ p.127 ~ p.131

±èöȫ(Kim Chul-Hong) - µ¿¾Æ´ëÇб³ Àǰú´ëÇÐ Á¤Çü¿Ü°úÇб³½Ç
¹ÚÁø¿ì(Park Jin-Woo) - µ¿¾Æ´ëÇб³ Àǰú´ëÇÐ Á¤Çü¿Ü°úÇб³½Ç

Abstract

ÀÎü¿¡¼­ °¡Àå Å« ±â°üÀÎ °ñ°Ý±ÙÀº ÅëÁõ°ú ±â´ÉÀå¾Ö¸¦ ÃÊ·¡ÇÒ ¼ö Àִµ¥, ÅëÁõ À¯¹ßÁ¡À̶ó´Â Ư¡ÀûÀÎ º´º¯À» °¡Áö´Â ±Ù ¸· ÅëÁõ ÁõÈıºÀÌ °ñ°Ý±ÙÀÇ °¡Àå ÈçÇÑ º´Àû »óȲ ÁßÀÇ ÇϳªÀÌ´Ù. ÅëÁõ À¯¹ßÁ¡Àº °ñ°Ý±Ù ³»ÀÇ taut band¶ó°í ºÒ¸®´Â ¶ì ¾È¿¡ Á¸ÀçÇÏ´Â °ú¹ÎÇÑ ÅëÁõ¼º ±¹¼Ò º´º¯À¸·Î ±¹¼Ò ÅëÁõ »Ó¸¸ ¾Æ´Ï¶ó ¿¬°üÅë ¹× ¸¸¼ºÀûÀÎ °üÀý¿îµ¿ Á¦ÇѰúµµ µ¿¹ÝµÈ´Ù. ´Ù¾çÇÑ Ä¡·á¹ýµéÀÌ ½ÃµµµÇ¾úÀ¸³ª ÅëÁõ À¯¹ßÁ¡ ÁÖ»ç¹ýÀÌ °¡Àå È¿À²ÀûÀÎ Ä¡·á¹ýÀ¸·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç ÀÌ Á¾¼³¿¡¼­´Â ±Ù¸· ÅëÁõ ÁõÈıºÀÇ ÀϹÝÀû º´Àΰú ÅëÁõ À¯¹ß ÁÖ»çÀÇ ¹æ¹ý¿¡ ´ëÇÏ¿© ¼Ò°³ÇϰíÀÚ ÇÑ´Ù.
Skeletal muscles which are the largest part of human body may develop pain and dysfunction. The myofascial pain syndrome that has trigger points as a unique characteristic is a major cause of morbidity. Trigger points are focal, hyperirritable painful areas located in a taut band of skeletal muscle. They produce local area pain and a referred pattern pain and often accompany chronic joint dysfunction. Various modalities are used to inactivate trigger points in myofascial pain syndrome. Trigger-point injection has been shown to be one of the most effective treatment modality to provide prompt relief of symptoms. This review article presents general concept of myofascial pain syndrome and technique of trigger point injection.

Ű¿öµå

Skeletal muscle, Trigger point, Myofascial pain syndrome, Trigger point injection
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå